parkinson glutathione oxidative ipsc crispr Frontiers Non-invasive CRISPR/Cas9 nanocapsules specifically edit
Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect CRISPR Cas9 Based Technology and Its Relevance to Gene Editing in Parkinson's Disease The Mitochondrial Interactome in Parkinson's and Huntington's Diseases Nature Cell and Science
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



